Post-approval studies (Phase 4)Study completedNCT00926289
What this trial is testing
Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension
Who this might be right for
Hypertension
Boehringer Ingelheim 894
Showing 2 of 2 results